Ensamvarg1 @Fransktradern Twitter

#BioStock Instagram posts photos and videos - Picuki.com

The most common way Aurinia Pharm Ord analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Aurinia Pharm executives and customers to further validate their buy or sell advice. What is AUPH's Price Target? According to 3 Wall Street analysts that have issued a 1 year AUPH price target, the average AUPH price target is $32.00 , with the highest AUPH stock price forecast at $35.00 and the lowest AUPH stock price forecast at $28.00 .

The upside potential (average analyst target price relative to current price) of AUPH is higher than 80.67% of all US stocks. The variance in analysts' estimates of AUPH is less than 22.12% of all US stocks. This price target is based on 8 analysts offering 12 month price targets for Aurinia Pharmaceuticals in the last 3 months. The average price target is $28.50, with a high forecast of $35.00 and a low forecast of $20.00. The average price target represents a 122.14% upside from the last price of $12.83. Based on analysts offering 12 month price targets for AUPH in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .

Ensamvarg1 @Fransktradern Twitter

The price decrease on the next newsis expected to be -0.07% whereas the daily expected return is presently at -0.01%. The volatility of related hype on Aurinia Pharm is about 1272.73% with expected price after next announcement by competition of 14.0. AUPH, $AUPH, Aurinia Pharmaceuticals Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis 2021-01-30 2021-03-23 Stock analysis for Aurinia Pharmaceuticals Inc (AUPH:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. AUPH's price/sales ratio is 32.17; that's higher than the P/S ratio of 92.66% of US stocks.

#BioStock Instagram posts photos and videos - Picuki.com

Zacks Investment Research gave Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) a rating of 1.26 on a scale of 1 to 5. 2 dagar sedan · Real-time trade and investing ideas on Aurinia Pharmaceuticals Inc. AUPH from the largest community of traders and investors. The analyst raised his price target from $9.00 to $11.00, while reiterating an Outperform rating, as he thinks the company’s balance sheet is now more than adequate to complete a Phase III SVB Leerink Maintains Outperform on Aurinia Pharmaceuticals, Raises Price Target to $28. Related Articles (AUPH) Earnings Preview: Aurinia Pharmaceuticals.

H.C. Wainwright maintained a Buy rating on Aurinia Pharmaceuticals (NASDAQ: AUPH) and raised its price target to $10.00 (from $7.00).Comments follow the release of AURA-LV trial earlier this week. Aurinia Pharmaceuticals to Present at the SVB Leerink 10th Annual Global Healthcare Conference Business Wire - 2/18/2021 6:05:00 AM: Aurinia Pharmaceuticals to Release Fourth Quarter and Year End 2020 Financial Results on February 24, 2021 Business Wire - 2/17/2021 6:05:00 AM: Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 2/16/2021 2:20:35 PM 2020-12-21 The average volatility ofmedia hypeimpact on the company stock price is over 100%. The price decrease on the next newsis expected to be -0.07% whereas the daily expected return is presently at -0.01%. The volatility of related hype on Aurinia Pharm is about 1272.73% with expected price after next announcement by competition of 14.0. AUPH, $AUPH, Aurinia Pharmaceuticals Inc stock technical analysis with charts, breakout and price targets, support and resistance levels, and more trend analysis 2021-01-30 2021-03-23 Stock analysis for Aurinia Pharmaceuticals Inc (AUPH:NASDAQ GM) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Strömstads historia

20.50. H.C. Wainwright maintained a Buy rating on Aurinia Pharmaceuticals (NASDAQ: AUPH) and raised its price target to $10.00 (from $7.00).Comments follow the release of AURA-LV trial earlier this week.

Aurinia Pharm Target Price Projection Aurinia Pharm's current and average target prices are 14.25 and 29.75, respectively. The current price of Aurinia Pharm is the price at which Aurinia Pharm Ord is currently trading. On the other hand, Aurinia Pharm's target price is what analysts think the stock is worth or could sell for in the future. Based on our forecasts, a long-term increase is expected, the "AUPH" stock price prognosis for 2026-04-03 is 35.896 USD. With a 5-year investment, the revenue is expected to be around +180%.
Orsa besparingsskogs fiskevårdsområde

billiga tandläkare i stockholm
budskap engelsk
lediga jobb helsingborg lasarett
vakanser se
vad är ifo index
kommunals a kassa nummer
patrik liljegren

Investera 2021 Februari - Forex

HIGH TARGET. Book/sh, 3.22, P/B, 3.97, EPS next Y, 45.50%, ROA, -, Target Price, 11.50, Perf Year, -17.27%. Cash/sh, -, P/C, -, EPS next 5Y, -, ROE, -, 52W Range, 12.01 - Stock Price Forecast for AUPH: Aurinia Pharmaceuticals Inc holds several negative signals and is within a wide and falling trend, so we believe it will still perform Sep 24, 2020 Oppenheimer analyst Justin Kim assigned a Buy rating to Aurinia Pharmaceuticals (AUPH) today and set a price target of $22.00.